院外感染性肺炎(Community Acquired Pneumonia):世界の治験レビュー(2014年下半期版)

◆英語タイトル:Community Acquired Pneumonia Global Clinical Trials Review, H2, 2014
◆商品コード:GDHC2435CTIDB
◆発行会社(リサーチ会社):GlobalData
◆発行日:2014年11月28日
◆ページ数:103
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥260,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥520,000見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD7,500 ⇒換算¥780,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

当調査レポートでは、世界における院外感染性肺炎(Community Acquired Pneumonia) 治療の臨床試験動向について調査・分析し、アジア太平洋/欧州/北米/中南米の主要国における治験件数、段階(フェーズ)別の治験件数、進捗状況別の治験件数、治験目標の達成状況、有望な薬剤、治験関連の最新ニュース、代表的な企業・大学・研究機関における治験概要、代表的な治験のプロファイルなどのデータをまとめてお届けいたします。

・イントロダクション
  - 院外感染性肺炎(Community Acquired Pneumonia)
  - 当レポートの概要
・院外感染性肺炎(Community Acquired Pneumonia):各地域別治験状況
  - 各国の治験件数及び平均被験者数
   アジア太平洋の主要国における治験件数
   欧州の主要国における治験件数
   北米の主要国における治験件数
   中東・アフリカの主要国における治験件数
   中南米の主要国における治験件数
・G7諸国での治験件数
・G7諸国での治験件数:段階別
・G7諸国での治験件数:進捗状況別
・段階(フェーズ)別の治験件数:進行中の治験(段階別)
・進捗状況別の治験件数
・治験目標の達成状況
・未完了の治験件数
・一定期間に採用された被験者
・スポンサーの種類別治験件数
・有望なスポンサー
・有望な薬剤
・治験のプロファイル
  - 代表的な企業における治験概要
  - 代表的な大学・研究機関における治験概要
・5つの代表的な治験のプロファイル
【レポートの概要】

Community Acquired Pneumonia Global Clinical Trials Review, H2, 2014

Summary

GlobalData’s clinical trial report, “Community Acquired Pneumonia Global Clinical Trials Review, H2, 2014″ provides data on the Community Acquired Pneumonia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Community Acquired Pneumonia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Community Acquired Pneumonia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Community Acquired Pneumonia 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Community Acquired Pneumonia to Infectious Disease Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Community Acquired Pneumonia to Infectious Disease Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Community Acquired Pneumonia 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Community Acquired Pneumonia Therapeutics Clinical Trials 30
Prominent Drugs 31
Latest Clinical Trials News on Community Acquired Pneumonia 32
Oct 03, 2014: FDA Grants Durata Therapeutics a Special Protocol Agreement for Its Phase 3 Study of DALVANCE in Hospitalized Community-Acquired Pneumonia 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Pfizer Inc. 33
Clinical Trial Overview of Pfizer Inc. 33
TaiGen Biopharmaceuticals Holdings Limited 35
Clinical Trial Overview of TaiGen Biopharmaceuticals Holdings Limited 35
Sanofi 36
Clinical Trial Overview of Sanofi 36
Actavis plc 37
Clinical Trial Overview of Actavis plc 37
Bayer AG 38
Clinical Trial Overview of Bayer AG 38
Melinta Therapeutics, Inc 39
Clinical Trial Overview of Melinta Therapeutics, Inc 39
Novartis AG 40
Clinical Trial Overview of Novartis AG 40
GlaxoSmithKline plc 41
Clinical Trial Overview of GlaxoSmithKline plc 41
AstraZeneca PLC 42
Clinical Trial Overview of AstraZeneca PLC 42
Abbott Laboratories 43
Clinical Trial Overview of Abbott Laboratories 43
Clinical Trial Overview of Top Institutes / Government 44
St. Antonius Hospital 44
Clinical Trial Overview of St. Antonius Hospital 44
University Hospital Basel 45
Clinical Trial Overview of University Hospital Basel 45
University of Milan 46
Clinical Trial Overview of University of Milan 46
HaEmek Medical Center 47
Clinical Trial Overview of HaEmek Medical Center 47
Medical Center Alkmaar 48
Clinical Trial Overview of Medical Center Alkmaar 48
Spanish National Health System 49
Clinical Trial Overview of Spanish National Health System 49
Carlos III Health Institute 50
Clinical Trial Overview of Carlos III Health Institute 50
Nagasaki Evaluation Organization for Clinical Interventions 51
Clinical Trial Overview of Nagasaki Evaluation Organization for Clinical Interventions 51
Ono Municipal Hospital 52
Clinical Trial Overview of Ono Municipal Hospital 52
University of Roma La Sapienza 53
Clinical Trial Overview of University of Roma La Sapienza 53
Five Key Clinical Profiles 54
Appendix 101
Abbreviations 101
Definitions 101
Research Methodology 102
Secondary Research 102
About GlobalData 103
Contact Us 103
Disclaimer 103
Source 103

List of Tables
Community Acquired Pneumonia Therapeutics, Global, Clinical Trials by Region, 2014* 7
Community Acquired Pneumonia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Community Acquired Pneumonia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Community Acquired Pneumonia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Community Acquired Pneumonia Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Community Acquired Pneumonia Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Community Acquired Pneumonia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
Community Acquired Pneumonia Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of Community Acquired Pneumonia to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 15
Community Acquired Pneumonia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Community Acquired Pneumonia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Community Acquired Pneumonia to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 18
Community Acquired Pneumonia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Community Acquired Pneumonia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Community Acquired Pneumonia Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Community Acquired Pneumonia Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Community Acquired Pneumonia Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Community Acquired Pneumonia Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Community Acquired Pneumonia Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Community Acquired Pneumonia Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Community Acquired Pneumonia Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Community Acquired Pneumonia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Community Acquired Pneumonia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 28
Community Acquired Pneumonia Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Community Acquired Pneumonia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Community Acquired Pneumonia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 33
Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by TaiGen Biopharmaceuticals Holdings Limited, 2014* 35
Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 36
Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis plc, 2014* 37
Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014* 38
Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Melinta Therapeutics, Inc, 2014* 39
Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 40
Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 41
Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 42
Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2014* 43
Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Antonius Hospital, 2014* 44
Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Basel, 2014* 45
Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Milan, 2014* 46
Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by HaEmek Medical Center, 2014* 47
Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical Center Alkmaar, 2014* 48
Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Spanish National Health System, 2014* 49
Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Carlos III Health Institute, 2014* 50
Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Nagasaki Evaluation Organization for Clinical Interventions, 2014* 51
Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Ono Municipal Hospital, 2014* 52
Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Roma La Sapienza, 2014* 53

List of Figures
Community Acquired Pneumonia Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Community Acquired Pneumonia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Community Acquired Pneumonia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Community Acquired Pneumonia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Community Acquired Pneumonia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Community Acquired Pneumonia Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Community Acquired Pneumonia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13
Community Acquired Pneumonia Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of Community Acquired Pneumonia to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 15
Community Acquired Pneumonia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Community Acquired Pneumonia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Community Acquired Pneumonia to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 18
Community Acquired Pneumonia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Community Acquired Pneumonia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Community Acquired Pneumonia Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Community Acquired Pneumonia Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Community Acquired Pneumonia Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Community Acquired Pneumonia Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Community Acquired Pneumonia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Community Acquired Pneumonia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 28
Community Acquired Pneumonia Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Community Acquired Pneumonia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Community Acquired Pneumonia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
GlobalData Methodology 102

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[院外感染性肺炎(Community Acquired Pneumonia):世界の治験レビュー(2014年下半期版)]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆